p53 is involved in several DNA repair pathways. Some of these require the speci®c transactivation of p53-dependent genes and others involve direct interactions between the p53 protein and DNA repair associated proteins. Previously, we have shown that p53 acts directly in Base Excision Repair (BER) when assayed under in vitro conditions. Our present data indicate that this involvement is independent of the transcriptional activity of the p53 molecule. We found that under both in vitro and in vivo conditions, a p53 transactivation-de®cient molecule, p53-22-23 was more ecient in BER activity than was wild type p53. However, mutations in the core domain or C-terminal alterations strongly reduced p53-mediated BER activity. These results are consistent with the hypothesis that the involvement of p53 in BER activity, a housekeeping DNA repair pathway, is a prompt and immediate one that does not involve the activation of p53 transactivation-dependent mechanisms, but rather concerns with the p53 protein itself. In an endogenous DNA damage status p53 is active in BER pathways as a protein and not as a transcription factor. Oncogene (2001) 20, 581 ± 589.
Introduction
The ability of any organism to propagate and maintain genomic integrity depends primarily on cellular mechanisms that are sensing and repairing dierent types of DNA lesions caused by intracellular and external DNA damaging agents.
The tumor suppressor protein p53 was described as being associated with various processes of DNA repair and recombination. The involvement of p53 in various DNA repair pathways was initially observed in Li ± Fraumeni syndrome cells (Wang et al., 1995) , and was suggested to be mediated by dierent p53 activities. It was found that the C-terminus of p53 is essential for sensing' and detecting damaged DNA. p53 can`sense' and form stable complexes with DNA damaged by ionizing radiation as well as with insertion/deletion mismatches. The C-terminus of wild type p53 was suggested to bind single stranded DNA and catalyze renaturation and annealing of complementary DNA strands (Yokote et al., 1998) . Wild-type p53 was also suggested to enhance DNA end joining. Using an episomal plasmid reactivation assay, it was found that the presence of wild type p53 enhanced rejoining of double strand breaks (Tang et al., 1999; Yang et al., 1997) . Another biochemical activity of p53 is the intrinsic 3'-to -5' exonuclease activity exhibited by the core domain of wild type but not by mutant p53 (Janus et al., 1999a,b; Mummenbrauer et al., 1996) .
p53 was suggested to be associated with DNA damage and repair in several ways. p53 was shown to transcriptionally transactivate DNA repair associated genes that are induced following genotoxic stress. These include GADD-45 (Dutta et al., 1993) , the O 6 -methylguanine-DNA methyltransferase (Grombacher et al., 1998) , p48 (Hwang et al., 1999) and a novel p53 responsive gene, p53R2 which encodes a subunit of the enzyme ribonucleotide reductase, that is speci®cally involved in p53 checkpoint for repair of damaged DNA (Tanaka et al., 2000) . Likewise, KARP-1 protein induction, that appears to play a role in mammalian double strand break repair, was completely dependent on the ataxia telangiectasia and p53 gene products, consistent with the presence of a p53 binding site within the second intron of the KARP-1 locus (Myung et al., 1998) .
Furthermore, p53 was shown to form complexes with DNA repair associated proteins such as XPB, XPD and p62 which are components of the TFIIH complex, thus coupling p53 with the basal transcription machinery and the Nucleotide Excision Repair pathway (Dutta et al., 1993; Miller et al., 1997; Wang et al., 1994a) . p53 also binds to other DNA repair proteins such as the Cockayne syndrome B protein (Wang et al., 1995) and PCNA (Chen et al., 1995; Flores-Rozas et al., 1994; Shivji et al., 1994) . Another partner of p53 is the single-stranded DNA binding protein RPA . This binding seems to be involved in upstream regulation of p53-dependent damage response (Abramova et al., 1997) . A number of recent studies suggest that Poly (ADP-ribose) polymerase, which is induced following DNA strand breaks, plays a role in the regulation of accumulation, activation and DNA binding of p53 following genotoxic stress (Oliver et al., 1999) .
The involvement of p53 in NER was also indicated by the observation that the capacity to remove cyclobutane pyrimidine dimers was signi®cantly reduced in human cells with defective p53 function (Wani et al., 1999) . Moreover, the global genomic repair of DNA adducts formed by a carcinogen was rapidly repaired in human ®broblasts expressing wild type p53 but not in p53 non-expressing cells (Lloyd and Hanawalt, 2000) . Other studies have implicated p53 in repair of both the transcribed and nontranscribed strands of DNA (Therrien et al., 1999) .
Recently, we have shown that overexpression of the temperature sensitive (ts) human or murine p53 mutant protein in its wild type conformation enhanced BER activity in an in vitro assay and that depletion of p53 from the nuclear extracts abolished this enhanced activity. This implies for the ®rst time a direct role for p53 in the BER pathway (Oer et al., 1999) . Furthermore, involvement of p53 in BER was also supported by the observation that Ref-1, which serves as an abasic site endonuclease, interacts with p53 and enhances p53 DNA binding and transactivation activities both in vitro and in vivo (Gaiddon et al., 1999) .
p53 was shown to be a transcription factor that both transactivates and transrepresses speci®c genes involved in controlling cell cycle and apoptosis. (Raycroft et al., 1990) . It is believed that following speci®c interaction of the p53 core domain with p53 responsive DNA sequences contained in p53 target genes promoters, the p53 N-terminus functions as the transactivation domain. p53 is known to be involved in other cellular growth control pathways such as growth arrest, apoptosis and dierentiation (Gottlieb and Oren, 1998) , some of which are mediated through the transcriptional activity of p53. p53 induced apoptosis was found to be transcription dependent in some studies (White, 1996) , while others have shown p53 dependent apoptosis in the absence of p53 driven transactivation (Caelles et al., 1994; Haupt et al., 1995) . The existence of ample evidence concerning the involvement of p53 in DNA repair pathways together with our data indicating a direct participation of p53 in BER prompted us to address the question of whether transactivation activity mediated by p53 plays a role in p53 associated BER. In this study we show that p53 is directly involved in the BER pathway in vivo. This involvement requires intact core and C-terminal domains, while the N-terminal domain mediated transcriptional activity is dispensable.
Results

Transactivation deficient p53 22
Gln -23
Ser stimulates BER in vitro
In order to demonstrate the role of p53 in DNA repair we established an in vitro experimental system that measures BER activity in nuclear extracts derived from cells varying in their p53 status. Brie¯y, the in vitro DNA repair assay that we adopted (Frosina et al., 1996; Wang et al., 1994b) consisted of two dierent sized plasmids; AP+ (3 kb), containing Apurinic/ Apyrimidinic (AP) sites and AP-(4.5 kb) lacking AP sites, incubated together with a nuclear cell extract and radioactively labeled nucleotide (a-32 P-dGTP). Upon completion of the reaction, the two plasmids were linearized, separated through an agarose gel and the levels of radioactivity, re¯ecting DNA repair synthesis, were measured by phosphorimaging. In our previous work, using murine p53Val135 ts mutant, we observed that BER activity measured in an in vitro assay was augmented by p53 at the permissive temperature (Oer et al., 1999) . Therefore, we speculated that the involvement of p53 in BER in vivo is probably transcription independent. To further elucidate this hypothesis and its relevance to p53 DNA repair associated activity in vivo, we established p53 null M1/2 cell lines expressing the human p53-22-23 mutant protein. This was done by infection of the paternal M1/2 cells with a retrovirus expressing the transcription de®cient p53 mutant. The mutation of two residues (Leu22 to Gln and Trp23 to Ser) within the p53 transactivation region was shown to abrogate its transactivation activity (Lin et al., 1994) . Single clones were isolated and p53-22-23 expression was con®rmed by Western blot analysis. Clones expressing comparable p53 protein levels were chosen for future experiments ( Figure 1a , note ts clone). Nuclear extracts were prepared and BER activity was measured at 328C, which is the permissive temperature at which p53 is expressed in wild type conformation. The upper gel in Figure 1b depicts the actual amount of DNA used in each reaction, while the lower gel represents the radioactive signal incorporated into the individual plasmids. Figure 1c illustrates the relative DNA repair synthesis estimated as the ratio of radioactivity detected in the individual samples and that of M1/2 nuclear cell extract prepared from a stable clone infected with a retrovirus coding for the Neomycin resistance gene (pLXSN). The basal activity observed in the M1/2 cell extract was signi®cantly enhanced by p53 (compare C (control) with p53-22-23 clone 12C and ts p53 in Figure 1c) . A twofold increase in the DNA repair synthesis was consistently observed, thus suggesting that this increment is a result of p53 expression. The similar level of BER enhancement in clones expressing either ts p53 or the transactivation de®cient mutant suggests that p53 transcriptional activity is not required for p53 associated BER.
In the above experiment ( Figure 1 ) the activity of p53-transactivation negative mutant was compared to that of the ts p53 mutant. Although it was shown that at the permissive temperature, the p53 ts acquires a wild type conformation and thus acts as a`bona-®de' wild type p53 protein, it was important to con®rm our observation in a system where wild type p53 is expressed. We used a transient transfection assay where the various p53 expressing plasmids were transfected into p53 null cells (K/O) and the BER activity in nuclear extracts obtained 24 h later was assayed in vitro. The expression of the dierent p53 mutants was driven by the strong and constitutive
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H Offer et al CMV promoter. Western blot analysis of these nuclear extracts ( Figure 2a ) exhibited equal levels of p53 protein encoded by the various p53 constructs. Surprisingly, BER activity in nuclear extracts obtained from cells transfected with the p53-22-23 mutant was even higher than that of the wild type p53. On the other hand, BER activity of cells transfected with a core mutation construct (273R/H) was comparable to the control vector (Figure 2b ,c).
To con®rm that the p53-22-23 mutant is indeed transactivation defective in our hands, we tested it in a p53-dependent reporter gene assay. We chose to use well characterized p53 responsive elements identi®ed inside the promoter of WAF-1. The expression of the Luciferase reporter was driven by the WAF-1 promoter. As can be seen in Figure 3 , luciferase expression was strongly induced by the wild type p53 expressing construct only. In contrast, the transactivation potential of p53-22-23 mutant was only slightly above the basal level of transactivation caused by the empty vector. Moreover, the p53 273R/H core mutant showed no signi®cant dierence when compared to the p53-22-23 mutant. The transactivation de®ciency of the p53-22-23 mutant was also evident when GADD-45-containing p53 responsive element upstream to a Luciferase gene was examined (Figure 3 ).
p53 dependent BER in vivo does not require p53 transactivation
To further investigate the mechanism that underlies involvement of p53 in BER it was important to establish an in vivo system. Our in vivo experimental system is based on the reactivation of a reporter construct that was damaged in vitro by heat and acid treatment as previously described (Henderson et al., 1989; McKay et al., 1999; Oer et al., 1999) and transiently cotransfected into K/0 p53 null cell line in the presence or absence of dierent p53 constructs. Twenty-four hours following transfection, luciferase activity of the reporter gene was measured. The expression of the luciferase gene was under a constitutively active CMV promoter (Figure 4a ). We plasmids of the various repair reactions were separated by gel electrophoresis and exposed to UV (upper gel) or analysed for radioactivity by phosphorimaging (lower gel) (b). Repair synthesis (%) in dierent M1/2 clones is calculated as described in Materials and methods (c) Figure 2 BER activity in vitro mediated by dierent p53 mutants. K/0 cell line was transiently transfected with dierent p53 constructs (0.5 mg DNA/plate) as indicated. Nuclear extracts were prepared and analysed for p53 expression by immunoblotting with PAb-421 (a) and BER activity in vitro as described in Figure 1b (b). Repair synthesis (%) is calculated as described in Materials and methods (c) found that the expression of target coding luciferase is decreased as a function of AP sites accumulated following the treatment (Figure 4b ). To examine the role of p53 in AP site repair in vivo we focused on the extent of damage (360 min) that gave us an optimal dierence of luciferase expression in cells following DNA repair. Although the expression of the luciferase gene is under the CMV promoter, which is p53 independent per se, we observed a wild type p53 dose dependent inhibitory eect on CMV-Luc expression (data not shown). This reduction is most likely a result of apoptosis induced by wild type p53 at the high doses. In the following experiments we have selected a concentration of 0.1 ng of p53 encoding plasmid, that by itself does not change the level of luciferase activity in comparison with the empty vector control ( Figure  4c) . However, this level of p53 was sucient to induce only 10 ± 15% of p53 induced WAF-1-luciferase activity as measured in a reporter gene experiment (data not shown). It should be noted that there was no variation in undamaged CMV induced luciferase expression when the various p53 coding constructs were used (Figure 4c ). Figure 4c represents the results of a typical repair experiment in vivo. As can be seen, a reduction in luciferase activity was evident following DNA damage. However, expression of a wild type p53, as well as of the p53-22-23 mutant, resulted in a signi®cant enhancement of luciferase expression, as compared to the control plasmid transfection. In contrast, p53 273R/H did not enhance the repair of the damaged reporter gene. To further support the data obtained above by a transient transfection of p53, we repeated the experiments using stable clones expressing dierent amounts of 22-23 p53 mutant. To that end, we used two clones expressing dierent levels of the protein (see Figure 4d , Western blot analysis) that were transfected with 0.5 mg DNA of AP sites containing CMV-Luciferase plasmid. In agreement with the above experiment we observed that clones expressing the transactivation de®cient p53 were more potent in the repair of AP site containing CMV-Luc plasmid as compared with the control clone ( Figure  4d ). The control is a stable clone generated by infection of M1/2 parental cells with a retrovirus containing only the bleomycine resistance gene (bleo). Interestingly, repair activity was directly correlated with the levels of the p53 transactivation de®cient mutant protein.
Indeed clone 22-23/1C exhibited higher levels of BER activity when compared with clone 22-23/12C. In conclusion, these two independent BER assays show that p53 facilitates the repair of AP-sites both in vitro and in vivo and that this activity is independent of its transcriptional activity.
BER activity in vivo is greatly affected by p53 level
According to several studies the onset of dierent p53 dependent activities such as growth arrest, dierentiation and apoptosis is correlated with the levels of the p53 protein in the cells (Kaneko and Tsukamoto, 1995; Ronen et al., 1996) . We were interested to test if p53 involvement in BER is correlated with p53 protein levels. To that end, we transiently transfected p53 null K/0 cells with a damaged reporter plasmid and increasing amounts of either wild type or p53-22-23 coding plasmids and measured BER activity as mentioned above. As shown in Figure 5a , repair activity associated with p53 and measured by reactivation of a damaged luciferase construct was reduced in a dose-dependent manner in wild type p53 transfected cells, and was not aected following transfection of the p53-22-23 construct. To explain the dierences in the repair capacity mediated by the two dierent constructs we tested the eect of the dierent amounts of p53 on cell viability. p53 null K/O cells were cotransfected with increasing amounts of dierent p53 constructs and GFP expressing plasmids. Forty-eight hours later, oating and adherent cells were collected, ®xed and stained with PI. Using FACS analysis, GFP positive cells were gated and analysed for their DNA content. As can be seen in Figure 5b , wild type p53 expression at high doses caused induction of apoptosis (28%), while p53-22-23 mutant induced cell death, at a level comparable with the empty vector transfection (3%).
Wild type core domain and intact C-terminus domain are essential for p53 involvement in BER Dierent mutations in the p53 gene are the most common genetic changes in human cancer (Hollstein et al., 1991) . However, their signi®cance for p53 associated DNA repair is still unclear. We were interested to characterize the importance of the dierent structural determinants of the p53 molecule in p53 associated BER activity. To that end we used several p53 point mutations in the core domain (143V/ A, 273 R/H) and deletions at the C-terminus (342-stop, 360-del). Importantly, all these mutations occur in human cancer (Hussain and Harris, 1998). K/0 cells were transiently cotransfected with the indicated p53 coding mutants (Figure 6a ) together with damaged reporter plasmid and 24 h later the luciferase activity was measured (Figure 6b) . In a parallel set of transfections, nuclear extracts of the cells transfected with the dierent p53 mutants were tested for BER activity in vitro (Figure 6c ). The pattern of BER was similar in both experimental systems used. Both wild type p53 and p53-22-23 mutant augment BER activity signi®cantly as compared to the p53 null K/0 cells transfected with the control vector, while core mutations and deletions in the C-terminus abrogate this augmentation. This suggests that while transactivation activity mediated by the N-terminus domain is dispensable for p53 associated BER, the integrity of both the core domain and the C-terminus is essential for this activity. 
Discussion
BER activity is considered to be the main pathway that is handling damaged DNA accumulated following endogenous stress such as that caused by DNA replication errors, by free radicals and by alkylation (Lindahl, 1993; Seeberg et al., 1995) . Our previous observation concerning the direct involvement of p53 in BER in vitro (Oer et al., 1999) prompted us to further investigate whether this p53-dependent BER activity also occurs in vivo and what are the essential molecular domains required for this activity. The fact that p53 may act as a transcriptional factor raises the question of whether this activity is also essential for p53 activity in BER. We found that the p53 transcription de®cient protein was as ecient as the wild type p53 in BER activity measured under both in vivo and in vitro conditions. The observation that p53 transcription de®cient protein was capable of reactivating a damaged reporter gene further con®rmed our original observations in vitro (Oer et al., 1999) , where transcription activity was not expected to occur.
Interestingly, transfection of the transactivation de®cient p53 protein into p53 7/7 cells induced a higher BER activity than that mediated by the wild type p53 protein. This can be explained by the fact that while the wild type p53 caused under these conditions apoptosis, p53-22-23 does not aect cell viability. Furthermore, both the transactivation de®cient p53 and the wild type p53 induced higher BER activity than that observed following the transfection of control vector or a p53 core mutant. The fact that the mutant seems to reduce the basal BER activity, further supports our conclusion that p53 core mutants may act in this pathway by a mechanism of gain of function (Oer et al., 1999) . This inhibition may explain the mechanism by which such mutations are ecient in promoting cancer.
It is worth mentioning that the p53 transactivation de®cient form, encoded by p53-22-23 mutant, was shown in several studies to be inactive in induction of apoptosis as well as in the transactivation of p53 target genes. Our present data further con®rm these observations. Furthermore, it was shown that this p53 mutant does not interact with the proteins of the TFIID complex and MDM-2 (Chang et al., 1995; Farmer et al., 1996; Lin et al., 1994) . This implies that the nature of p53 involvement in the BER pathway is dierent than that in other cell cycle control pathways. Taken together, these data show that p53-dependent BER repair occurs in vivo and does not depend on p53 transactivation activity.
Comparative analysis of various p53 tumor derived mutants indicated that both the core domain and the last 30 amino acids of the p53 C-terminus are required for p53 associated BER repair activity in vitro and in vivo. The role of the C-terminus in DNA repair is substantiated by the observation that the presence of wild type p53 enhanced rejoining of double stranded breaks and that this is dependent on nonspeci®c DNA binding activity mediated by the Cterminal domain and is independent on the transcriptional activation by p53 (Tang et al., 1999) . It was recently shown that p53 undergoes speci®c interaction with Ref-1, an AP site endonuclease, which actively participates in BER. The interaction between the two proteins is suggested to be through the p53 Cterminus domain (Gaiddon et al., 1999) . This fact can explain the abolishment of p53 associated BER in vitro and in vivo, while the C-terminus deletion mutants were used. Moreover, taking into consideration that p53 is known to interact with dierent forms of damaged DNA, it is possible that p53 recognizes AP sites as well.
Our in vivo experiments show that while expression of low levels of p53 facilitate BER activity, higher levels reduced it and instead induced apoptosis. This is in agreement with the suggested model that p53 levels dictate the onset of a speci®c p53-dependent pathway in the cells (Oer et al., submitted; Ronen et al., 1996) . -22-23 (b) It is known that in non-stressed cells p53 exists mostly in the`latent', transcriptional inert state, while the protein level is low. Our results strongly indicate that in this form p53 actively participates in DNA repair pathways, such as BER, and does not interfere with cell proliferation. Following genotoxic stress, p53 undergoes transcriptional activation, accompanied by signi®cant protein accumulation (Kastan et al., 1991) . This`activated' state of p53, which most likely corresponds to the high level of overexpression in our experiments, is competent for apoptosis induction, but apparently less competent for p53 associated BER. Indeed, we found that transactivation de®cient mutant of p53 actively participates in BER, independently of the protein levels expressed. The possibility that transcriptional active form of p53, resulting of cellular stress, may participate in other pathways of DNA repair, such as NER (Hwang et al., 1999) , can not be excluded.
Our ®ndings indicating to an important role of p53 in the BER pathway, which is mainly essential for the elimination of endogenous types of DNA damage, taken together with the fact that the p53 protein is constitutively expressed in cells, further agree with the`dual role model' suggested before (Janus et al., 1999a) . In addition to the pivotal role p53 plays in response to an exogenous stress, suggested before, p53 is also central for the maintenance of genome stability under physiological conditions. 
Materials and methods
Cell lines
M1/2, a p53 non-producer myeloid cell line and a derived clone expressing human temperature sensitive p53 (p53 143V/ A), were used in the present experiments. Clones expressing the p53-22-23 transactivation de®cient mutant were generated by the infection of M1/2 cells with a p53-22-23 carrying retrovirus by the methodology described previously (Yee et al., 1994) . Clones were continuously grown in DMEM containing 10% fetal calf serum and conditioned medium. K/0 ®broblasts derived from p53 7/7 mice (Donehower, 1996) were maintained in DMEM medium supplemented with 10% fetal calf serum (FCS). All these cell lines were grown at 378C in a humidi®ed atmosphere of 5% CO 2 in air.
Plasmids and transfections
All p53 expression vectors were expressed from the CMV immediate-early promoter: p53 143V/A and p53 273 R/H (provided by Dr B Vogelstein), p53-22-23 (provided by Dr A Levine), p53 360-del and p53 340-stop (Zhou et al., 1999) .
The dierent reporter constructs CMV-Luc, WAF1-Luc, GADD45-Luc were provided by Dr M Oren. K/0 cells were grown in a complete medium and replated 16 ± 24 h before transfection. Cells were transfected by FuGENE 
Western blot analysis
For Western blot analysis, 10 6 cells were lysed in sample buer (140 mM Tris pH 6.8; 22.4% Glycerol; 6% SDS; 10% b-mercaptoethanol and 0.02% Bromophenol Blue), boiled and loaded on 10% polyacrylamide gels containing SDS. Proteins were transferred to nitrocellulose membranes. The p53 protein was detected using p53 monoclonal antibody PAb-421. The protein-antibody complexes were detected by using an HRP-conjugated secondary antibody (BoehringerMannheim), using the super-signal enhanced chemiluminescene system (Pierce).
Flow cytometry analysis of cell cycle and apoptosis
Forty-eight hours after DNA transfection, adherent and oating cells were collected, and ®xed in 70% ethanol at 7208C for 30 min at least. Fixed cells were washed twice with PBE (PBS, EDTA 50 mM, 0.5% BSA) and exposed to Propidium Iodide (PI 50 mg/ml) and RNase A (100 mg/ml) for 30 min at 378C prior to FACS analysis (FACS-Sort; Becton Dickinson).
Harvesting of cells and FACS analysis were performed on the same day to avoid loss of GFP staining. Cells (5000) with high FL1 intensity were gated and then analysed for their DNA content (PI). Data were analysed with CELLQuest software (Becton Dickinson). Cells with DNA content less than 2N (sub G1 fraction) were designated as apoptotic.
Luciferase assay
For luciferase assays, K/0 and M1/2 cells were seeded in 24-well plates and transfected with 500 ng of CMV-Luciferase constructs (damaged or undamaged, as indicated). 0.1 ng of p53 expression vectors were added where indicated. The total amount of DNA in each transfection was kept constant by complementing with empty-CMV vector control DNA. Twenty-four hours later cells were rinsed twice with cold Phosphate-Buered Saline (PBS) and lysed in the wells by cell culture lysis reagent (Promega) for 15 min at room temperature. One hundred ml of lysate was quantitated for luciferase activity in the presence of luciferin (Promega) and ATP (Promega) using a Turner Design Model 20 Luminometer. Transfections were done in triplicates.
BER assay
BER assay was performed as previously described (Oer et al., 1999) . Brie¯y, the assay was carried out in 25 ml containing 40 mM Tris pH 7.6, 12 mM MgCl 2 , 1 mM DTT, 0.1 mM each of dTTP, dATP, dCTP, 0.01 mM dGTP, 3% PEG, 0.3 mg depurinated pSP65 plasmid, 0.3 mg non-treated plasmid, 0.25 ml [a-P
32
-dGTP], 30 mM KCl, and 0.5 ± 1.5 mg of nuclear extracts. Samples were incubated at 378C for 15 min. Five ml of stop buer (120 mM EDTA, 1.2% SDS) were added to each sample and incubated for 10 min at 608C. Twenty mg of proteinase K were added and incubated at 378C for 1 h. Then 170 ml TE were added. Samples were phenol/chloroform extracted and ethanol precipitated. DNA was linearized with BamHI and fractionated through a 0.7% agarose gel in TBE. Gels were UV photographed, dried and analysed by phosphorimaging. DNA repair synthesis is presented by PSL (Hunger et al., 1994) , calculated by dividing net counts obtained from the phosphorimager (taken as PSL-background: AP-in each individual lane) by the DNA content assessed by UV absorption. Standard deviations are calculated in all experiments.
Construction of DNA molecules containing AP sites
The plasmids pSP65 (3 Kb) and pSP65-8-3 (4.5 Kb) were puri®ed using the Qiagen Kit and further puri®ed on a CsCl gradient. Depurination of pSP65 was carried out by heating 11 mg DNA in 40 ml buer containing 0.01 M sodium citrate and 0.1 M KCl (pH 5.0) at 708C for 45 min. The depurinated DNA was neutralized by the addition of 10 ml of 0.2 M TrisHCl (pH 7.8). pSP65 served as the AP+ plasmid which contains the AP sites while pSP65-8-3, AP7, served as a control. The CMV-Luciferase (CMV-Luc) plasmid was damaged and puri®ed before transfections by the same methodology.
